Total Funding
33
6
Total FundingPost-IPO Debt raised
Growth Score 33 in past quarter
-3 pts
Heat Score 6 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2595958
BG Medicine is a life sciences company developing biomarker-based diagnostic tests for the cardiovascular sectors.
- Paul Sohmer: President & CEOPast Role: Viracor-IBT Laboratories, President and Chief Executive Officer
- Stephen Hall: Executive Vice President, Chief Financial OfficerPast Role: TriPath Imaging, Chief Financial Officer
About the Company
BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostic tests based on biomarkers for high-value market opportunities in healthcare that they identify.

